Transaction · 0000929638-26-001708

Cormorant Asset Management, LP

Cormorant Asset Management, LP, 10%, reported an open-market or private sale at BRIGHT MINDS BIOSCIENCES INC. involving 109331.000000 shares for an estimated $9785124.50. Reported holdings after the transaction were 950000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code S10%
DRUGBRIGHT MINDS BIOSCIENCES INC.
Trade date
Apr 28, 2026
Filing date
Apr 30, 2026
View on SEC Insider profile
Estimated value-$9.78MShares × reported price
Shares traded109k$89.50 per share
Holdings after950kIndirect · See Footnotes
% of reported position traded10.32%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,059,331 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

DRUG price since this filing

Daily closing prices, with the filing date and available return windows
DRUG · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0000929638-26-001708
Common Shares
Transaction date
Apr 28, 2026
Filed Apr 30, 2026, 08:07 PM · 2d delay
Shares
109,331 sh
$89.50 per share
Estimated value
-$9.78M
Computed from shares × price
Holdings after
950,000 sh
Indirect · See Footnotes

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Large Sale
Filing-only score

+4 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector No10% NoOther Yes
Footnotes & amended
  1. F1

    Cormorant Asset Management, LP ("Cormorant") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the "Master Fund"). Cormorant Global Healthcare GP, LLC ("GP LLC") serves…

Original filing · 0000929638-26-001708
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

DRUG